High-Yield Deep-Dive • Rhinology
FRCS (ORL-HNS) + ABOHNS + EBEORL-HNS relevant
Sinonasal Inverted Papilloma: stage it, find the base, prevent recurrence.
Recurrence is often a technique problem — not “bad luck”. The high-yield move is to map the attachment (often hinted by CT focal hyperostosis), then perform a complete endoscopic resection with base clearance + bone drilling.
Exam line: “Endoscopic resection with identification of the attachment site and drilling/curettage of underlying bone.”
The 60-second overview (what examiners want)
Inverted papilloma is benign on paper — but behaves like a locally aggressive tumour. Your marks come from attaching the right words to the right steps.
- Unilateral sinonasal mass → think IP until proven otherwise (especially if papillomatous/bleeds).
- CT focal hyperostosis often points to the attachment site (plan to drill this).
- Krouse staging describes extent and helps frame the operation (T1/T2 = endoscopic workhorses).
- Definitive management is complete surgical resection — not “polypectomy”.
- Long-term endoscopic follow-up is essential (late recurrences happen).
Educational content only — always follow local guidelines and senior input for real cases.
Imaging pearls: map the base before you pick up the drill
The high-yield imaging job is not “confirm a mass” — it’s “find the attachment and define boundaries”.
CT (bone windows): the attachment clue
- Focal hyperostosis = common attachment site clue → plan to drill/curette there.
- Assess sinus walls + corridors (maxillary, ethmoid, frontal recess, sphenoid).
- Look for bone destruction/irregular erosion (raises concern for malignancy or aggressive behaviour).
MRI: tumour vs secretions + extent
- Defines skull base/orbital proximity; clarifies “tumour vs trapped mucus”.
- Classic teaching: convoluted/cerebriform pattern on T2/contrast (useful, not mandatory).
- Suspicious focal changes may suggest dysplasia/malignant transformation → plan accordingly.
| Question you must answer | What you look for | Why it matters |
|---|---|---|
| Where is the attachment? | CT focal hyperostosis; intra-op correlation | Attachment clearance is the recurrence lever |
| How far does it extend? | Sinuses involved (ethmoid/maxillary/frontal/sphenoid); corridors | Determines whether extended endoscopic access is required |
| Any red flags for malignancy? | Irregular bone destruction; extrasinus extension; suspicious enhancement | Changes staging, surgical margins, and adjuvant planning |
Krouse staging (the exam-friendly version)
Know the staging well enough to say it out loud without thinking — then link it to the operation.
| Krouse stage | Extent (high yield) | Typical approach framing |
|---|---|---|
| T1 | Confined to nasal cavity (often lateral nasal wall/middle meatus) | Endoscopic excision + base clearance + drilling |
| T2 | Osteomeatal complex / ethmoid ± medial maxillary involvement | Endoscopic (often ethmoidectomy + targeted access) |
| T3 | Other maxillary walls and/or frontal/sphenoid involvement | Endoscopic extended approaches (e.g., endoscopic medial maxillectomy, Draf where needed) |
| T4 | Extrasinus/extranasal extension or associated malignancy | Often combined/open + oncology planning as required |
How to “use” the stage in your answer
- State the stage based on extent.
- State the principle: complete resection + attachment site clearance.
- State the access you need (standard endoscopic vs extended endoscopic vs combined).
Surgical technique: the recurrence-proof plan
This is the make-or-break section. The winning answer is a sequence: exposure → identify base → remove tumour → drill base → marsupialise cavities → document follow-up.
Step-by-step operative approach (endoscopic-first)
- Pre-op mapping: review CT bone windows for hyperostosis; plan access corridors (maxillary/ethmoid/frontal recess/sphenoid).
- Exposure: create working space (uncinectomy, wide middle meatal antrostomy, ethmoidectomy as required).
- Identify the attachment: correlate endoscopic findings with imaging clues; don’t be satisfied with “where it’s bulging”.
- Resect the tumour: controlled excision (avoid casual piecemeal “polypectomy” mentality).
- Clear the base: remove involved mucosa around the attachment; then drill/curette the underlying hyperostotic bone until healthy bone is reached.
- Extended access when needed: for maxillary sinus attachment beyond medial wall, consider endoscopic medial maxillectomy (or extended endonasal approaches) to reach all recesses.
- Marsupialise for surveillance: widen the surgical cavity so the base and recesses are visible on follow-up endoscopy.
- Histology: ensure complete sampling; address dysplasia/malignancy if present (MDT pathway).
When to say “endoscopic medial maxillectomy” (high yield)
Use this term when you need dependable access to maxillary sinus recesses (e.g., anterior/lateral/inferior walls), especially if imaging suggests attachment beyond the medial maxillary wall. The exam point is not the name — it’s the logic: your approach must reach the attachment and allow base drilling.
| Scenario | What you say | Why |
|---|---|---|
| T1 (nasal cavity/lateral wall only) | Endoscopic excision + base clearance + drilling | Limited disease, endoscopic is standard, low morbidity |
| T2 (OMC/ethmoid ± medial maxillary) | Endoscopic ethmoidectomy/antrostomy + targeted base drilling | Access corridors let you reach typical attachments |
| T3 (frontal/sphenoid or maxillary recess attachment) | Extended endoscopic approach (e.g., endoscopic medial maxillectomy/Draf) + base drilling | Must reach hidden recesses to prevent residual disease |
| T4 / malignancy / extrasinus extension | MDT staging + combined/open as required | Oncologic principles and margins dominate |
Recurrence reduction: your checklist
Think of recurrence as “residual attachment” until proven otherwise.
- Pre-op: locate hyperostosis and plan access to it.
- Intra-op: find true attachment, not the bulkiest part.
- Resect mucosa at attachment with a margin.
- Drill/curette underlying bone at the base.
- Open cavities wide enough for clinic visualisation.
- Document the attachment site in op note (future you will thank you).
- “Polypectomy” language or behaviour.
- Leaving a narrow antrostomy that hides the recesses.
- Assuming “no bone destruction” = low recurrence risk.
- Short follow-up (late recurrences exist).
Malignancy risk (what to say)
IP has a recognised risk of dysplasia/malignant transformation. In answers, state: histology review + MDT pathway if carcinoma is found, and ensure follow-up is long-term.
Surveillance: how to follow these patients (board-ready)
Your follow-up plan should show you understand both recurrence and malignant transformation risk.
| Time after surgery | What you do | Why |
|---|---|---|
| 0–12 months | Regular endoscopic review (more frequent early) | Early recurrences and healing-related changes are easiest to catch here |
| Years 1–5 | Ongoing endoscopy; imaging if concern on exam | Recurrence can be subtle; clinical exam drives imaging |
| >5 years | Long-term follow-up (often annually) | Late recurrence can occur; don’t “discharge at 5 years” by default |
Practise this in exam format
Turn recognition + technique into marks with board-style stems, timed sets, and analytics.
Also available: FRCS free trial · EBEORL-HNS free trial · ENT subscriptions
FAQ
What is a sinonasal inverted papilloma (IP)?
A benign Schneiderian tumour that can behave aggressively locally, with a tendency to recur if incompletely removed and a recognised risk of dysplasia or malignant transformation.
Why is CT hyperostosis important?
Focal hyperostosis on CT bone windows often corresponds to the tumour’s attachment site. Identifying and clearing that base (including drilling/curettage of underlying bone) is a key recurrence-reduction step.
How is Krouse staging used in exams?
It describes disease extent (T1–T4). It helps you justify the surgical access you need — but the principle stays the same: complete resection with attachment site clearance.
What is the definitive management for a T1/T2 inverted papilloma?
Endoscopic excision with identification of the attachment site, removal of involved mucosa, and drilling/curettage of the underlying bone at the base to minimise recurrence.
When should you mention “endoscopic medial maxillectomy”?
When access is needed to maxillary sinus recesses (anterior/lateral/inferior walls) or when imaging suggests the attachment sits beyond the medial maxillary wall. The key is that your approach must reach the base for complete clearance.
How long should patients be followed?
Long-term endoscopic surveillance is recommended because recurrences can be late. Imaging is guided by symptoms or suspicious endoscopic findings.
Keep learning
Useful next clicks for mocks, trials, and structured revision.